[go: up one dir, main page]

NO20030397L - Amyloid målsökende billeddannende midler og anvendelser av samme - Google Patents

Amyloid målsökende billeddannende midler og anvendelser av samme

Info

Publication number
NO20030397L
NO20030397L NO20030397A NO20030397A NO20030397L NO 20030397 L NO20030397 L NO 20030397L NO 20030397 A NO20030397 A NO 20030397A NO 20030397 A NO20030397 A NO 20030397A NO 20030397 L NO20030397 L NO 20030397L
Authority
NO
Norway
Prior art keywords
same
imaging agents
targeting imaging
amyloid targeting
amyloid
Prior art date
Application number
NO20030397A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030397D0 (no
Inventor
Francine Gervais
Xianqi Kong
Robert Chalifour
David Migneault
Original Assignee
Neurochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurochem Inc filed Critical Neurochem Inc
Publication of NO20030397D0 publication Critical patent/NO20030397D0/no
Publication of NO20030397L publication Critical patent/NO20030397L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20030397A 2000-07-25 2003-01-24 Amyloid målsökende billeddannende midler og anvendelser av samme NO20030397L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22080800P 2000-07-25 2000-07-25
US09/915,092 US20020115717A1 (en) 2000-07-25 2001-07-24 Amyloid targeting imaging agents and uses thereof
PCT/CA2001/001071 WO2002007781A2 (fr) 2000-07-25 2001-07-25 Agents d'imagerie ciblant les substances amyloides et utilisation desdits agents

Publications (2)

Publication Number Publication Date
NO20030397D0 NO20030397D0 (no) 2003-01-24
NO20030397L true NO20030397L (no) 2003-03-24

Family

ID=26915211

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030397A NO20030397L (no) 2000-07-25 2003-01-24 Amyloid målsökende billeddannende midler og anvendelser av samme

Country Status (6)

Country Link
US (1) US20020115717A1 (fr)
EP (1) EP1303311A2 (fr)
AU (1) AU2001278319A1 (fr)
CA (1) CA2416617A1 (fr)
NO (1) NO20030397L (fr)
WO (1) WO2002007781A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1051137A1 (zh) * 1999-07-09 2003-07-25 Isis Innovation Limited 抑制疾病的化合物和製備移植用的細胞
WO2002064084A2 (fr) * 2000-11-02 2002-08-22 Cornell Research Foundation, Inc. Detection diagnostique de multiphotons in vivo et imagerie d'une maladie neurodegenerative
US20040049134A1 (en) * 2002-07-02 2004-03-11 Tosaya Carol A. System and methods for treatment of alzheimer's and other deposition-related disorders of the brain
DE10230141B4 (de) * 2002-07-04 2004-07-15 Priontype Gmbh Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc)
US20040204344A1 (en) * 2003-01-22 2004-10-14 Xudong Huang Amyloid-binding, metal-chelating agents
WO2004113275A2 (fr) * 2003-06-23 2004-12-29 Neurochem (International) Limited Methodes et compositions pour traiter les maladies liees a l'amyloide
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20050214222A1 (en) * 2004-02-13 2005-09-29 Mckinnon Stuart J In vivo imaging of amyloid plaques in glaucoma using intravenous injectable dyes
WO2006026184A2 (fr) * 2004-08-20 2006-03-09 Washington University Peptides de perméation de la barrière sang-cerveau
EP1828111A2 (fr) * 2004-11-12 2007-09-05 Neurochem (International) Limited Procedes et compositions fluorees pour le traitement de maladies associees aux amyloides
WO2006085149A2 (fr) * 2004-12-22 2006-08-17 Neurochem (International) Limited Methodes et compositions de traitement de maladies liees a l'amyloide
US9335331B2 (en) * 2005-04-11 2016-05-10 Cornell Research Foundation, Inc. Multiplexed biomarkers for monitoring the Alzheimer's disease state of a subject
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
US20070049638A1 (en) * 2005-07-21 2007-03-01 Neurochem (International) Limited Polymorphic forms of 3-amino-1-propanesulfonic acid
BRPI0620637A2 (pt) * 2005-12-22 2011-11-16 Neurochem Int Ltd uso de compostos na preparação de medicamentos para a prevenção ou o tratamento de nefropatia diabética, complicação de desordem renal e dislipidemia, redução dos nìveis de lipìdeos e ácido úrico no soro, e aumento do clearance de creatinina e da função renal
PT2089417E (pt) 2006-10-12 2015-04-14 Bhi Ltd Partnership Métodos, compostos, composições e veículos para administrar o ácido 3-amino-1-propanossulfónico
CA2673022A1 (fr) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Procedes, composes et compositions permettant de traiter des troubles metaboliques et le diabete
HRP20220401T4 (hr) 2008-02-14 2024-09-27 Eli Lilly And Company Nova vizualizacijska sredstva za detektiranje neurološke disfunkcije
JP5591720B2 (ja) * 2009-01-29 2014-09-17 株式会社林原 抗神経変性疾患剤
JPWO2010087315A1 (ja) * 2009-01-29 2012-08-02 株式会社林原生物化学研究所 抗アルツハイマー病剤
JPWO2010087313A1 (ja) * 2009-01-29 2012-08-02 株式会社林原生物化学研究所 神経突起伸展促進剤
US9023767B2 (en) * 2009-05-07 2015-05-05 Memorial Sloan-Kettering Cancer Center γ-Secretase substrates and methods of use
CN103502466A (zh) 2010-09-07 2014-01-08 斯隆－凯特林纪念癌症中心 用于γ-分泌酶测定的方法和组合物
US9683017B2 (en) 2014-07-17 2017-06-20 University Tennessee Research Foundation Inhibitory peptides of viral infection
EP3186273A4 (fr) * 2014-08-26 2018-05-02 University of Tennessee Research Foundation Immunothérapie de ciblage de l'amyloïdose
US10493172B2 (en) 2016-06-02 2019-12-03 California Institute Of Technology Gas-filled structures and related compositions, methods and systems to image a target site
US11118210B2 (en) 2016-07-28 2021-09-14 California Institute Of Technology Genetically engineered gas vesicle gene clusters, genetic circuits, vectors, prokaryotic cells, compositions, methods and systems for contrast-enhanced imaging
US11786218B2 (en) 2019-01-07 2023-10-17 California Institute Of Technology Burst ultrasound reconstruction with signal templates and related methods and systems
EP3908656A4 (fr) 2019-01-07 2022-10-05 California Institute of Technology Systèmes d'expression de vésicule de gaz, constructions de vésicule de gaz et circuits génétiques associés, vecteurs, cellules de mammifère, hôtes, compositions, procédés et systèmes
WO2020198728A1 (fr) * 2019-03-28 2020-10-01 California Institute Of Technology Compositions, procédés et systèmes pour cavitation basée sur des vésicules gazeuses
CN111398465B (zh) * 2020-04-03 2021-08-10 北京先通国际医药科技股份有限公司 一种pet显像剂前体fcpha及其顺式异构体的测定方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840294A (en) * 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
US6054114A (en) * 1996-05-08 2000-04-25 Massachusetts Institute Of Technology Organometallic ligands for the localization and quantification of amyloid in vivo and in vitro
US6261537B1 (en) * 1996-10-28 2001-07-17 Nycomed Imaging As Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
JP2004500354A (ja) * 1999-11-29 2004-01-08 ニューロケム　インコーポレーティッド 全ｄ体ペプチドを含む、アルツハイマー病およびアミロイド関連疾患の予防および処置のためのワクチン
AU2001261728A1 (en) * 2000-05-17 2001-11-26 Bristol-Myers Squibb Pharma Company Use of small molecule radioligands for diagnostic imaging
US6589504B1 (en) * 2000-09-22 2003-07-08 Pharmacia & Upjohn Company Compounds and methods for diagnosing and treating amyloid-related conditions

Also Published As

Publication number Publication date
WO2002007781A2 (fr) 2002-01-31
CA2416617A1 (fr) 2002-01-31
EP1303311A2 (fr) 2003-04-23
US20020115717A1 (en) 2002-08-22
NO20030397D0 (no) 2003-01-24
AU2001278319A1 (en) 2002-02-05
WO2002007781A3 (fr) 2002-10-31

Similar Documents

Publication Publication Date Title
NO20030397L (no) Amyloid målsökende billeddannende midler og anvendelser av samme
DE60113409D1 (de) Kombinierte impedanzbildgebung und mammographie
EE200200550A (et) Karbamaatsed kaspaasi inhibiitorid ja nende kasutamine
DE60131227D1 (de) Toner und Bildherstellungsverfahren
ID30590A (id) Celana sekali pakai jenis-celana pendek
AR027938A1 (es) Compuestos uracilo y utilizacion de los mismos
DE50112013D1 (de) Deodorantien und antiperspirantien
NO20040469L (no) Heterocykliske forbindelser samt fremstilling og anvendelse derav
EP1412378A4 (fr) Aptameres et antiaptameres
NO20031407L (no) Glukopyranosyloksybenzylbenzen-derivater og medisinske sammensetninger inneholdende det samme
NO20022656D0 (no) Caspaseinhibitorer og anvendelse derav
ATE450663T1 (de) Verschleissteil und -anordnung
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
DK1370128T3 (da) Kombineret ballepresse og ballevikler
NO20005440D0 (no) Pakkebaserte personlig utstyrsarrangementer og - fremgangsmÕter
NO20025158D0 (no) Lipidpreparat og anvendelse derav
PT1390516E (pt) Novos vectores de expressão e uso dos mesmos
DE60120291D1 (de) Endoskop und Endoskopkapsel
NO20023737L (no) Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
PL360839A1 (pl) Zastosowanie szczepów owczych parapoksywirusów przeciw zwłóknieniu narządów
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina
NO20032821D0 (no) Sea-trosy og beslektede fremgangsmåter
PT1267621E (pt) Composicoes e metodos herbicidas sinergeticos
NO20034785L (no) Farmas degree ytiske kombinasjoner basert på pyridoindolonderivater og anticancer-midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application